Supriya Jagga

Dr. Supriya Jagga

Medicine, Harvard Medical School, Boston, Massachusetts, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Ashish Ranjan SharmaAshish Ranjan Sharma
Ashish Ranjan Sharma
Supriya JaggaSupriya Jagga
Supriya Jagga
SLSang-Soo Lee
Sang-Soo Lee
JNJu-Suk Nam
Ju-Suk Nam
Osteoarthritis (OA) is a common debilitating joint disorder, affecting large sections of the population with significant disability and impaired quality of life. During OA, functional units of joints comprising cartilage and subchondral bone undergo uncontrolled catabolic and anabolic remodeling processes to adapt to local biochemical and biological signals. Changes in cartilage and subchondral bone are not merely secondary manifestations of OA but are active components of the disease, contributing to its severity. Increased vascularization and formation of microcracks in joints during OA have suggested the facilitation of molecules from cartilage to bone and vice versa. Observations from recent studies support the view that both cartilage and subchondral bone can communicate with each other through regulation of signaling pathways for joint homeostasis under pathological conditions. In this review we have tried to summarize the current knowledge on the major signaling pathways that could control the cartilage-bone biochemical unit in joints and participate in intercellular communication between cartilage and subchondral bone during the process of OA. An understanding of molecular communication that regulates the functional behavior of chondrocytes and osteoblasts in both physiological and pathological conditions may lead to development of more effective strategies for treating OA patients.

1 January 2017 in The Korean Journal of Physiology & Pharmacology
Verified
Journal Article
Open access
PDF file
LNLich Thi Nguyen
Lich Thi Nguyen
YLYeon-Hee Lee
Yeon-Hee Lee
Ashish Ranjan SharmaAshish Ranjan Sharma
Ashish Ranjan Sharma
JPJong-Bong Park
Jong-Bong Park
Supriya JaggaSupriya Jagga
Supriya Jagga
JNJu-Suk Nam
Ju-Suk Nam
Nguyen LT, et al. Korean J Physiol Pharmacol. 2017 Mar;21(2):205-213. https://doi.org/10.4196/kjpp.2017.21.2.205

11 January 2017 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
JNJu‐Suk Nam
Ju‐Suk Nam
Ashish Ranjan SharmaAshish Ranjan Sharma
Ashish Ranjan Sharma
Supriya JaggaSupriya Jagga
Supriya Jagga
DLDong‐Hyun Lee
Dong‐Hyun Lee
GSGarima Sharma
Garima Sharma
SLSang-Soo Lee
Sang-Soo Lee

27 May 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YYYe Yuan
Ye Yuan
Supriya JaggaSupriya Jagga
Supriya Jagga
JMJanaina S. Martins
Janaina S. Martins
RRRakshya Rana
Rakshya Rana
PPPaola Divieti Pajevic
Paola Divieti Pajevic
Eva S. LiuEva S. Liu
Eva S. Liu
Osteocytes remodel the perilacunar matrix and canaliculi. X-linked hypophosphatemia (XLH) is characterized by elevated serum levels of fibroblast growth factor 23 (FGF23), leading to decreased 1,25 dihydroxyvitamin D3 (1,25D) production and hypophosphatemia. Bones from mice with XLH (Hyp) have enlarged osteocyte lacunae, enhanced osteocyte expression of genes of bone remodeling, and impaired canalicular structure. The altered lacuno-canalicular (LCN) phenotype is improved with 1,25D or anti-FGF23 antibody treatment, pointing to roles for 1,25D and/or phosphate in regulating this process. To address whether impaired 1,25D action results in LCN alterations, the LCN phenotype was characterized in mice lacking the vitamin D receptor (VDR) in osteocytes (VDRf/f;DMP1Cre+). Mice lacking the sodium phosphate transporter NPT2a (NPT2aKO) have hypophosphatemia and high serum 1,25D levels, therefore the LCN phenotype was characterized in these mice to determine if increased 1,25D compensates for hypophosphatemia in regulating LCN remodeling. Unlike Hyp mice, neither VDRf/f;DMP1Cre+ nor NPT2aKO mice have dramatic alterations in cortical microarchitecture, allowing for dissecting 1,25D and phosphate specific effects on LCN remodeling in tibial cortices. Histomorphometric analyses demonstrate that, like Hyp mice, tibiae and calvariae in VDRf/f;DMP1Cre+ and NPT2aKO mice have enlarged osteocyte lacunae (tibiae: 0.15±0.02μm2(VDRf/f;DMP1Cre-) vs 0.19±0.02μm2(VDRf/f;DMP1Cre+), 0.12±0.02μm2(WT) vs 0.18±0.0μm2(NPT2aKO), calvariae: 0.09±0.02μm2(VDRf/f;DMP1Cre-) vs 0.11±0.02μm2(VDRf/f;DMP1Cre+), 0.08±0.02μm2(WT) vs 0.13±0.02μm2(NPT2aKO), p<0.05 all comparisons) and increased immunoreactivity of bone resorption marker Cathepsin K (Ctsk). The osteocyte enriched RNA isolated from tibiae in VDRf/f;DMP1Cre+ and NPT2aKO mice have enhanced expression of matrix resorption genes that are classically expressed by osteoclasts (Ctsk, Acp5, Atp6v0d2, Nhedc2). Treatment of Ocy454 osteocytes with 1,25D or phosphate inhibits the expression of these genes. Like Hyp mice, VDRf/f;DMP1Cre+ and NPT2aKO mice have impaired canalicular organization in tibia and calvaria. These studies demonstrate that hypophosphatemia and osteocyte-specific 1,25D actions regulate LCN remodeling. Impaired 1,25D action and low phosphate levels contribute to the abnormal LCN phenotype observed in XLH.

17 August 2020 in Materials
Verified
Journal Article
Open access
PDF file
Ashish Ranjan SharmaAshish Ranjan Sharma
Ashish Ranjan Sharma
Supriya JaggaSupriya Jagga
Supriya Jagga
CCChiranjib Chakraborty
Chiranjib Chakraborty
SLSang-Soo Lee
Sang-Soo Lee
Biomaterials are designed to replace and augment living tissues in order to provide functional support to skeletal deformities. However, wear debris produced from the interfaces of metal implants initiates inflammatory bone loss, causing periprosthetic osteolysis. Lately, fibroblast-like synoviocytes (FLS) have been shown to play a role in wear-debris-induced osteolysis. Thus, here we have tried to understand the underlying mechanism of FLS involvement in wear-debris-induced osteolysis. Our results demonstrate that the effects of Ti particle (1:100 cell-to-Ti particle ratio) on FLS can induce Cox-2 expression and activate NFkB signaling. Moreover, the mRNA expression of pro-inflammatory cytokines such as IL-6, IL-8, IL-11, IL-1β, and TNFα was found to be elevated. However, among these pro-inflammatory cytokines, the mRNA and protein levels of only IL-6, IL-1β, and TNFα were found to be significantly higher. Ti particles activated extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) as an early response in FLS. Co-inhibition of ERK and JNK signaling pathways by their specific inhibitors (PD9805 and SP600125, respectively) resulted in the suppression of mRNA and protein levels of IL-6, IL-1β, and TNFα in FLS. Taken together, targeting ERK and JNK MAPKs in FLS might provide a therapeutic option for reducing the secretion of bone-resorbing pro-inflammatory cytokines, thus preventing periprosthetic osteolysis.

1 August 2017 in Chinese Journal of Natural Medicines
Verified
Journal Article
Closed access
JNJu-Suk Nam
Ju-Suk Nam
Supriya JaggaSupriya Jagga
Supriya Jagga
ASAshish Ranjan Sharma
Ashish Ranjan Sharma
JLJoon-Hee Lee
Joon-Hee Lee
JPJong Bong Park
Jong Bong Park
SLSang-Soo Lee
Sang-Soo Lee